FDA Adverse Event Injury Summary report: N

RECOVERY FILTER SYSTEM

MDR report key: 9877857 · Received March 25, 2020

Report

Report Number
2020394-2020-01954
Event Type
Injury
Date Received
March 25, 2020
Date of Event
April 6, 2006
Report Date
August 17, 2020
Manufacturer
BARD PERIPHERAL VASCULAR, INC.
Product Code
DTK
PMA / PMN Number
K031328
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
DE, US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

AS THE LOT NUMBER FOR THE DEVICE WAS NOT PROVIDED, A MANUFACTURING REVIEW COULD NOT BE PERFORMED. THE SAMPLE WAS NOT RETURNED TO THE MANUFACTURER FOR INSPECTION/EVALUATION. THEREFORE, THE INVESTIGATION OF THE REPORTED EVENT IS INCONCLUSIVE. BASED UPON THE AVAILABLE INFORMATION, THE DEFINITIVE ROOT CAUSE FOR THIS EVENT IS UNKNOWN. THE INSTRUCTIONS FOR USE (IFU) IS ADEQUATE FOR THE REPORTED DEVICE/PATIENT CODE(S) AND PROVIDES GENERAL INSTRUCTIONS FOR USE, AS WELL AS WARNINGS, PRECAUTIONS AND POTENTIAL COMPLICATIONS ASSOCIATED WITH THE DEVICE. UPON RECEIPT OF NEW OR ADDITIONAL INFORMATION, A FOLLOW-UP REPORT WILL BE SUBMITTED AS APPLICABLE. JOURNAL ARTICLE CITATION: SAEED, I., GARCIA, M., MCNICHOLAS, K. (2006). RIGHT VENTRICULAR MIGRATION OF A RECOVERY IVC FILTER¿S FRACTURED WIRE WITH SUBSEQUENT PERICARDIAL TAMPONADE. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 29(4), 685¿686. DOI: 10.1007/S00270-005-0136-7.

Description of Event or Problem · 0

IT WAS REPORTED IN AN ARTICLE IN THE JOURNAL OF CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY TITLED " RIGHT VENTRICULAR MIGRATION OF A RECOVERY IVC FILTER FRACTURED WIRE WITH SUBSEQUENT PERICARDIAL TAMPONADE " THAT 4 MONTHS AFTER FILTER PLACEMENT, SHORT ARM OF THE FILTER WAS MIGRATED TO THE RIGHT VENTRICLE AND PROTRUDING THROUGH IT CAUSING LACERATION, HEMOPERICARDIUM AND CARDIAC TAMPONADE. A STERNOTOMY REQUIRED FOR REPAIR OF THE LACERATION AND THEN MIGRATED ARM AND FILTER WAS REMOVED. ABOUT 4 DAYS POSTOPERATIVELY, LUNG PERFUSION STUDY FINDINGS WERE RELATED TO THE PULMONARY EMBOLISM (PE) WHICH REQUIRED AN ADDITIONAL INTERVENTION. THE PATIENT WAS DISCHARGED AFTER STABLE CONDITION.

Additional Manufacturer Narrative · 1

AS THE LOT NUMBER FOR THE DEVICE WAS NOT PROVIDED, A MANUFACTURING REVIEW COULD NOT BE PERFORMED. THE SAMPLE WAS NOT RETURNED TO THE MANUFACTURER FOR INSPECTION/EVALUATION. THEREFORE, THE INVESTIGATION OF THE REPORTED EVENT IS INCONCLUSIVE. BASED UPON THE AVAILABLE INFORMATION, THE DEFINITIVE ROOT CAUSE FOR THIS EVENT IS UNKNOWN. THE INSTRUCTIONS FOR USE (IFU) IS ADEQUATE FOR THE REPORTED DEVICE/PATIENT CODE(S) AND PROVIDES GENERAL INSTRUCTIONS FOR USE, AS WELL AS WARNINGS, PRECAUTIONS AND POTENTIAL COMPLICATIONS ASSOCIATED WITH THE DEVICE. UPON RECEIPT OF NEW OR ADDITIONAL INFORMATION, A FOLLOW-UP REPORT WILL BE SUBMITTED AS APPLICABLE. (B)(4). JOURNAL ARTICLE CITATION: SAEED, I., GARCIA, M., MCNICHOLAS, K. (2006). RIGHT VENTRICULAR MIGRATION OF A RECOVERY IVC FILTER¿S FRACTURED WIRE WITH SUBSEQUENT PERICARDIAL TAMPONADE. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 29(4), 685¿686. DOI: 10.1007/S00270-005-0136-7.

Description of Event or Problem · 1

IT WAS REPORTED IN AN ARTICLE IN THE JOURNAL OF CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY TITLED " RIGHT VENTRICULAR MIGRATION OF A RECOVERY IVC FILTER FRACTURED WIRE WITH SUBSEQUENT PERICARDIAL TAMPONADE " THAT 4 MONTHS AFTER FILTER PLACEMENT, SHORT ARM OF THE FILTER WAS MIGRATED TO THE RIGHT VENTRICLE AND PROTRUDING THROUGH IT CAUSING LACERATION, HEMOPERICARDIUM AND CARDIAC TAMPONADE. A STERNOTOMY REQUIRED FOR REPAIR OF THE LACERATION AND THEN MIGRATED ARM AND FILTER WAS REMOVED. ABOUT 4 DAYS POSTOPERATIVELY, LUNG PERFUSION STUDY FINDINGS WERE RELATED TO THE PULMONARY EMBOLISM (PE) WHICH REQUIRED AN ADDITIONAL INTERVENTION. THE PATIENT WAS DISCHARGED AFTER STABLE CONDITION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
342943 RECOVERY FILTER SYSTEM VENA CAVA FILTER DTK BARD PERIPHERAL VASCULAR, INC. UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 66 YR Required Intervention INTRAVENOUS HEPARIN| INTRAVENOUS HEPARIN